Phio Pharmaceuticals Corp Stock Z Score

PHIO Stock  USD 0.69  0.02  2.82%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Phio Pharmaceuticals Piotroski F Score and Phio Pharmaceuticals Valuation analysis.
  
At this time, Phio Pharmaceuticals' Capital Expenditure Coverage Ratio is very stable compared to the past year. At this time, Phio Pharmaceuticals' Interest Expense is very stable compared to the past year. As of the 22nd of June 2024, Preferred Stock And Other Adjustments is likely to grow to about 3 M, while Depreciation And Amortization is likely to drop about 115.8 K.

Phio Pharmaceuticals Corp Company Z Score Analysis

Phio Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Phio Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Phio Pharmaceuticals is extremely important. It helps to project a fair market value of Phio Stock properly, considering its historical fundamentals such as Z Score. Since Phio Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phio Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phio Pharmaceuticals' interrelated accounts and indicators.
0.90.25-0.97-0.580.03-0.04-0.021.00.17-0.590.110.380.440.54-0.040.770.77-0.3-0.04-0.04
0.90.53-0.87-0.70.26-0.06-0.460.89-0.08-0.690.030.460.450.73-0.060.820.82-0.4-0.06-0.06
0.250.53-0.24-0.740.5-0.51-0.710.25-0.76-0.31-0.240.610.640.77-0.510.610.62-0.73-0.51-0.51
-0.97-0.87-0.240.580.06-0.010.02-0.97-0.140.60.1-0.4-0.42-0.58-0.01-0.79-0.790.29-0.01-0.01
-0.58-0.7-0.740.58-0.360.50.45-0.570.220.750.2-0.66-0.64-0.920.5-0.71-0.710.840.50.5
0.030.260.50.06-0.36-0.1-0.520.03-0.48-0.160.330.050.00.38-0.1-0.03-0.03-0.25-0.1-0.1
-0.04-0.06-0.51-0.010.5-0.10.14-0.050.20.240.14-0.21-0.67-0.251.0-0.23-0.230.651.01.0
-0.02-0.46-0.710.020.45-0.520.14-0.010.540.390.16-0.27-0.18-0.560.14-0.32-0.320.340.140.14
1.00.890.25-0.97-0.570.03-0.05-0.010.17-0.590.120.370.450.53-0.050.760.76-0.3-0.05-0.05
0.17-0.08-0.76-0.140.22-0.480.20.540.17-0.280.26-0.23-0.26-0.370.2-0.25-0.260.280.20.2
-0.59-0.69-0.310.60.75-0.160.240.39-0.59-0.280.09-0.35-0.24-0.640.24-0.46-0.460.470.240.24
0.110.03-0.240.10.20.330.140.160.120.260.09-0.28-0.18-0.270.14-0.29-0.290.280.140.14
0.380.460.61-0.4-0.660.05-0.21-0.270.37-0.23-0.35-0.280.60.76-0.210.650.65-0.72-0.21-0.21
0.440.450.64-0.42-0.640.0-0.67-0.180.45-0.26-0.24-0.180.60.55-0.670.670.67-0.82-0.67-0.67
0.540.730.77-0.58-0.920.38-0.25-0.560.53-0.37-0.64-0.270.760.55-0.250.750.75-0.75-0.25-0.25
-0.04-0.06-0.51-0.010.5-0.11.00.14-0.050.20.240.14-0.21-0.67-0.25-0.23-0.230.651.01.0
0.770.820.61-0.79-0.71-0.03-0.23-0.320.76-0.25-0.46-0.290.650.670.75-0.231.0-0.57-0.23-0.23
0.770.820.62-0.79-0.71-0.03-0.23-0.320.76-0.26-0.46-0.290.650.670.75-0.231.0-0.57-0.23-0.23
-0.3-0.4-0.730.290.84-0.250.650.34-0.30.280.470.28-0.72-0.82-0.750.65-0.57-0.570.650.65
-0.04-0.06-0.51-0.010.5-0.11.00.14-0.050.20.240.14-0.21-0.67-0.251.0-0.23-0.230.651.0
-0.04-0.06-0.51-0.010.5-0.11.00.14-0.050.20.240.14-0.21-0.67-0.251.0-0.23-0.230.651.0
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

Based on the company's disclosures, Phio Pharmaceuticals Corp has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Phio Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phio Pharmaceuticals' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phio Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Phio Pharmaceuticals by comparing valuation metrics of similar companies.
Phio Pharmaceuticals is currently under evaluation in z score category among its peers.

Phio Pharmaceuticals Institutional Holders

Institutional Holdings refers to the ownership stake in Phio Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Phio Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Phio Pharmaceuticals' value.
Shares
Blackrock Inc2024-03-31
1.0
Sabby Management Llc2024-03-31
0.0
Citigroup Inc2023-12-31
0.0
Renaissance Technologies Corp2024-03-31
0.0
Morgan Stanley - Brokerage Accounts2024-03-31
0.0
Anson Funds Management Lp2024-03-31
0.0
Geode Capital Management, Llc2023-12-31
0.0
Jpmorgan Chase & Co2023-12-31
0.0
Virtu Financial Llc2024-03-31
30.9 K
Cetera Advisors Llc2024-03-31
30.4 K
Cetera Investment Advisers2024-03-31
30.4 K

Phio Fundamentals

About Phio Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Phio Pharmaceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phio Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phio Pharmaceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Phio Stock

When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:
Check out Phio Pharmaceuticals Piotroski F Score and Phio Pharmaceuticals Valuation analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.52)
Return On Assets
(0.70)
Return On Equity
(1.45)
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.